Stock Events

Stock Events

CervoMed 

$4.15
0
+$0.14+3.49% Friday 07:15

Statistics

Day High
4.18
Day Low
4.01
52W High
-
52W Low
-
Volume
29
Avg. Volume
-
Mkt Cap
38.4M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19MayExpected
Q3 2025
Q4 2025
Next
-0.88
-0.81
-0.73
-0.66
Expected EPS
-0.788
Actual EPS
N/A

Financials

-167.29%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
19.48MRevenue
-32.58MNet Income

Analyst Ratings

22Average Price Target
The highest estimate is 31.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CRVO.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap111.97B
Medtronic is a major player in the medical devices sector, directly competing with CervoMed in multiple healthcare technology markets.
Boston Scientific
BSX
Mkt Cap91.83B
Boston Scientific competes with CervoMed in developing advanced medical devices for various therapeutic areas.
Stryker
SYK
Mkt Cap129.89B
Stryker operates in the same sectors as CervoMed, particularly in orthopedics and neurotechnology, making them direct competitors.
Abbott Laboratories
ABT
Mkt Cap174.29B
Abbott Laboratories offers a broad range of medical devices and diagnostics, overlapping with CervoMed's product lines.
Intuitive Surgical
ISRG
Mkt Cap160.05B
Intuitive Surgical provides robotic-assisted surgical systems, competing with CervoMed's innovations in medical technology.
Zimmer Biomet
ZBH
Mkt Cap18.22B
Zimmer Biomet competes in the musculoskeletal healthcare sector, directly challenging CervoMed's offerings in orthopedic devices.
Edwards Lifesciences
EW
Mkt Cap45.23B
Edwards Lifesciences specializes in heart valve therapy and critical care, areas where CervoMed also operates.
Baxter International
BAX
Mkt Cap8.85B
Baxter International competes with CervoMed in the development and manufacturing of medical products, including hospital and renal care devices.
Resmed
RMD
Mkt Cap33.41B
ResMed is known for its sleep and respiratory care devices, competing with CervoMed's products in similar therapeutic areas.

About

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood"brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
Show more...
CEO
ISIN
US15713L1098

Listings

STU
DE
DP8.STU
F
DE
DP8.F
XNAS
US
CRVO
BOATS
BOATS
CRVO.BOATS

0 Comments

Share your thoughts

FAQ

What is CervoMed stock price today?▼
The current price of CRVO.BOATS is $4.15 USD — it has increased by +3.49% in the past 24 hours. Watch CervoMed stock price performance more closely on the chart.
What is CervoMed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange CervoMed stocks are traded under the ticker CRVO.BOATS.
What is CervoMed market cap?▼
Today CervoMed has the market capitalization of 38.4M
When is the next CervoMed earnings date?▼
CervoMed is going to release the next earnings report on May 19, 2026.
What were CervoMed earnings last quarter?▼
CRVO.BOATS earnings for the last quarter are -0.88 USD per share, whereas the estimation was -0.87 USD resulting in a -1.65% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is CervoMed revenue for the last year?▼
CervoMed revenue for the last year amounts to 19.48M USD.
What is CervoMed net income for the last year?▼
CRVO.BOATS net income for the last year is -32.58M USD.
In which sector is CervoMed located?▼
CervoMed operates in the Other sector.
When did CervoMed complete a stock split?▼
CervoMed has not had any recent stock splits.